A Canadian cohort study showed that dietary iron supplementation was associated with a low risk of breast cancer, and heme iron was positively related with the risk of the ER and or PR positive breast cancer subtypes in postmenopausal women (Chang et al., 2020). The gene discussed is ESR1; the disease is breast carcinoma.